NEW YORK (GenomeWeb) – Quanterix on Thursday announced the completion of an $8.5 million private placement led by T. Rowe Price.

The funding is a follow-on to the firm's Series D financing round, which raised $46 million in March 2016, and will be used to develop new instruments, expand Quanterix's assay menu, and "meet global demand for the company's proprietary platform across therapeutic markets," it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.